Want to join the conversation?
$ICUI agreed to buy all of $PFE's global infusion therapy business, Hospira Infusion Systems (HIS). After deal closure, $PFE will own about 16.6% of $ICUI. $ICUI's financial advisors were Barclays and Wells Fargo Securities. Goldman Sachs and Guggenheim Securities served as $PFE's financial advisors for the transaction.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.